Cargando…

Lymphoplasmacellular mucositis ameliorated by α4β7 integrin inhibitor vedolizumab in a patient with ulcerative colitis

Detalles Bibliográficos
Autores principales: Shalabi, Doaa, Sethi, Mansha, Okon, Lauren, Debes, Gudrun F., Lee, Jason B., Nikbakht, Neda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6677862/
https://www.ncbi.nlm.nih.gov/pubmed/31388533
http://dx.doi.org/10.1016/j.jdcr.2019.06.002
_version_ 1783440969448816640
author Shalabi, Doaa
Sethi, Mansha
Okon, Lauren
Debes, Gudrun F.
Lee, Jason B.
Nikbakht, Neda
author_facet Shalabi, Doaa
Sethi, Mansha
Okon, Lauren
Debes, Gudrun F.
Lee, Jason B.
Nikbakht, Neda
author_sort Shalabi, Doaa
collection PubMed
description
format Online
Article
Text
id pubmed-6677862
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-66778622019-08-06 Lymphoplasmacellular mucositis ameliorated by α4β7 integrin inhibitor vedolizumab in a patient with ulcerative colitis Shalabi, Doaa Sethi, Mansha Okon, Lauren Debes, Gudrun F. Lee, Jason B. Nikbakht, Neda JAAD Case Rep Case Report Elsevier 2019-07-31 /pmc/articles/PMC6677862/ /pubmed/31388533 http://dx.doi.org/10.1016/j.jdcr.2019.06.002 Text en © 2019 by the American Academy of Dermatology, Inc. Published by Elsevier, Inc. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Shalabi, Doaa
Sethi, Mansha
Okon, Lauren
Debes, Gudrun F.
Lee, Jason B.
Nikbakht, Neda
Lymphoplasmacellular mucositis ameliorated by α4β7 integrin inhibitor vedolizumab in a patient with ulcerative colitis
title Lymphoplasmacellular mucositis ameliorated by α4β7 integrin inhibitor vedolizumab in a patient with ulcerative colitis
title_full Lymphoplasmacellular mucositis ameliorated by α4β7 integrin inhibitor vedolizumab in a patient with ulcerative colitis
title_fullStr Lymphoplasmacellular mucositis ameliorated by α4β7 integrin inhibitor vedolizumab in a patient with ulcerative colitis
title_full_unstemmed Lymphoplasmacellular mucositis ameliorated by α4β7 integrin inhibitor vedolizumab in a patient with ulcerative colitis
title_short Lymphoplasmacellular mucositis ameliorated by α4β7 integrin inhibitor vedolizumab in a patient with ulcerative colitis
title_sort lymphoplasmacellular mucositis ameliorated by α4β7 integrin inhibitor vedolizumab in a patient with ulcerative colitis
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6677862/
https://www.ncbi.nlm.nih.gov/pubmed/31388533
http://dx.doi.org/10.1016/j.jdcr.2019.06.002
work_keys_str_mv AT shalabidoaa lymphoplasmacellularmucositisamelioratedbya4b7integrininhibitorvedolizumabinapatientwithulcerativecolitis
AT sethimansha lymphoplasmacellularmucositisamelioratedbya4b7integrininhibitorvedolizumabinapatientwithulcerativecolitis
AT okonlauren lymphoplasmacellularmucositisamelioratedbya4b7integrininhibitorvedolizumabinapatientwithulcerativecolitis
AT debesgudrunf lymphoplasmacellularmucositisamelioratedbya4b7integrininhibitorvedolizumabinapatientwithulcerativecolitis
AT leejasonb lymphoplasmacellularmucositisamelioratedbya4b7integrininhibitorvedolizumabinapatientwithulcerativecolitis
AT nikbakhtneda lymphoplasmacellularmucositisamelioratedbya4b7integrininhibitorvedolizumabinapatientwithulcerativecolitis